Loading...
Utility of mTOR Inhibition in Hematologic Malignancies
The mammalian target of rapamycin (mTOR) is an intracellular serine/threonine kinase that exists as a downstream component of numerous signaling pathways. The activation of mTOR results in the production of proteins involved in cell metabolism, growth, proliferation, and angiogenesis. Aberrant activ...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AlphaMed Press
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228224/ https://ncbi.nlm.nih.gov/pubmed/21632450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0318 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|